Go to Page # Page of 54
loading

TNBC: How Far Are We from a Precision Medicine Approach?

 Yuan Yuan MD PhD
  14th-Feb-2019
Description: Triple-negative breast cancer (TNBC) refers to any breast cancer that doesn't express the genes for ER (estrogen receptor), PR (progesterone receptor) and HER2/neu.
Views: 4344
Domain: Medical
Category: Therapy
Contributing Organization: City of Hope
 ‐ More of their Presentations
Contents:
TNBC: How Far Are We from a Precision
Medicine Approach?
Yuan Yuan, MD, PhD
Associate Professor
Department of Medical Oncology & Therapeutics Research
City of Hope Multidisciplinary Approaches to Cancer Symposium 2018

DISCLOSURE

• Grant/Research Support from Puma, Eisai,
Novartis, Merck, Pfizer, Genentech
• Consultant for Puma
• Speakers Bureau for Eisai

Outline
• Overview ... See more

Recent Presentations

...
22 July, 2019
Tine Peeters
21 July, 2019

FDA's Approach to the Opioids Crisis

FDA is working in a prioritized way in multiple areas to confront opioid overdoses while working to ensure patients receive appropriate pain treatment.

...
20 July, 2019